Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.

Goodyear CS, Narita M, Silverman GJ.

J Immunol. 2004 Mar 1;172(5):2870-7.

2.

Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.

Corcos D, Grandien A, Vazquez A, Dunda O, Lorès P, Bucchini D.

J Immunol. 2001 Mar 1;166(5):3083-9.

3.
4.
5.

In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire.

Grönwall C, Kosakovsky Pond SL, Young JA, Silverman GJ.

J Immunol. 2012 Jul 15;189(2):850-9. doi: 10.4049/jimmunol.1200245. Epub 2012 Jun 13.

7.
8.

Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.

Kenny JJ, Rezanka LJ, Lustig A, Fischer RT, Yoder J, Marshall S, Longo DL.

J Immunol. 2000 Apr 15;164(8):4111-9.

11.
13.

Annexin V binds to positively selected B cells.

Dillon SR, Constantinescu A, Schlissel MS.

J Immunol. 2001 Jan 1;166(1):58-71.

14.
15.

Association of B-1 B cells with follicular dendritic cells in spleen.

Wen L, Shinton SA, Hardy RR, Hayakawa K.

J Immunol. 2005 Jun 1;174(11):6918-26.

16.

Ig knock-in mice producing anti-carbohydrate antibodies: breakthrough of B cells producing low affinity anti-self antibodies.

Benatuil L, Kaye J, Cretin N, Godwin JG, Cariappa A, Pillai S, Iacomini J.

J Immunol. 2008 Mar 15;180(6):3839-48.

17.
18.
19.

Selection during development of VH11+ B cells: a model for natural autoantibody-producing CD5+ B cells.

Hardy RR, Wei CJ, Hayakawa K.

Immunol Rev. 2004 Feb;197:60-74. Review.

PMID:
14962187
20.

Transgenic human lambda 5 rescues the murine lambda 5 nullizygous phenotype.

Donohoe ME, Beck-Engeser GB, Lonberg N, Karasuyama H, Riley RL, Jäck HM, Blomberg BB.

J Immunol. 2000 May 15;164(10):5269-76.

Supplemental Content

Support Center